Literature DB >> 29103134

Androgenic alopecia in a postmenopausal Sicilian baroness.

G Borzì1, F Trimarchi2, M Russo3.   

Abstract

Entities:  

Keywords:  Androgenic alopecia; Hyperandrogenism in postmenopausal woman; Mandralisca museum

Mesh：

Year:  2017        PMID： 29103134     DOI： 10.1007/s40618-017-0787-7

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  5 in total

1.  Antonello da Messina: Virgin Annunciate.

Authors:  F Trimarchi; G Russo
Journal:  J Endocrinol Invest       Date:  2015-08-11       Impact factor: 4.256

2.  Androgen- and cortisol-secreting adrenocortical adenoma may also be "subclinical".

Authors:  B Ambrosi; E Costa; L Bonavina
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

3.  How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.

Authors:  P Moghetti; E Carmina; V De Leo; A Lanzone; F Orio; R Pasquali; V Toscano
Journal:  J Endocrinol Invest       Date:  2015-04-03       Impact factor: 4.256

Review 4.  Hyperandrogenism after menopause.

Authors:  Marios C Markopoulos; Evanthia Kassi; Krystallenia I Alexandraki; George Mastorakos; Gregory Kaltsas
Journal:  Eur J Endocrinol       Date:  2014-09-15       Impact factor: 6.664

5.  Occult leydig cell tumour and androgen-receptor positive breast cancer in a woman with severe hyperandrogenism.

Authors:  Giovanna Saraceno; Valeria Barresi; Francesco Trimarchi; Salvatore Cannavo
Journal:  J Ovarian Res       Date:  2013-07-01       Impact factor: 4.234
  5 in total
  2 in total

1.  Joseph Boruwlaski: the last court dwarf of the History.

Authors:  F Trimarchi
Journal:  J Endocrinol Invest       Date:  2018-03-20       Impact factor: 4.256

2.  Endo&Art why Diana is depicted with mild androgenic alopecia?

Authors:  A Gambineri; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2021-06-17       Impact factor: 4.256
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.